Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Randomized Controlled Trial

NCT06812637 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06812637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06812637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Randomized Controlled Trial
Lead sponsor
Kafrelsheikh University
Phase
Phase 1
Overall status
Completed
Start date
April 6, 2024
Completion date
September 2, 2024
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer (dfu), exosomes